Advaxis News

Latest Advaxis News

Disclaimer: IPD Group, the publisher of EIN News, is an independent news monitoring company. There is no affiliation between IPD Group and Advaxis. EIN News Report: Advaxis is a media monitoring website that has not been generated, sponsored or otherwise approved by Advaxis.

The Universe WatchList: Great Wall Builders Ltd. (GWBU), Advaxis, Inc. (ADXS), SEFE Inc. (SEFE), Sunpeaks Ventures, Inc.
15 May 16:57 GMT

… 26% on $2 million traded. Advaxis, Inc (ADXS) was also on … DoMark International, Inc. ADXS - Advaxis, Inc. SEFE - SEFE, Inc …
Advaxis Retires $4.5 Million in Debt, Adds $1,240,000 in New Financing
15 May 12:22 GMT

… to Advaxis. As part of this agreement, multiple covenants restricting Advaxis fundraising activities have been waived. In addition, Advaxis has … state securities laws. About Advaxis, Inc. Advaxis is a clinical-stage biotechnology company …
Advaxis Announces Cancer Research UK Initiates Phase 1/2 Clinical Trial of ADXS-HPV for the Treatment of Head and Neck ...
9 May 20:51 GMT

… : www.cancerresearchuk.org. About Advaxis, Inc. Advaxis is a clinical-stage biotechnology company … . For more information please visit: advaxis.com | Facebook | twitter | LinkedIn Forward-Looking … on any forward-looking statements. Contact: Advaxis, Inc. Diana Moore, 609-452-9814 Director …
Advaxis commences enrollment in ADXS-HPV Phase 1/2 study for head and neck cancer
8 May 13:53 GMT

Advaxis, Inc., (OTCBB: ADXS), a leader … . Moore, Chairman & CEO of Advaxis commented, "We are pleased …
Advaxis Announces Cancer Research UK Initiates Phase 1/2 Clinical Trial of ADXS-HPV for the Treatment of Head and Neck C
8 May 11:24 GMT

… : www.cancerresearchuk.org. About Advaxis, Inc. Advaxis is a clinical-stage biotechnology company … . For more information please visit: advaxis.com | Facebook | twitter | LinkedIn Forward-Looking … reliance on any forward-looking statements. Advaxis, Inc. Diana Moore, 609-452-9814 Director …
Advaxis Announces Abstracts Accepted for Poster Presentation at ASCO Annual Meeting 2012
2 May 11:03 GMT

… Science and Operations at Advaxis. About Advaxis, Inc. Advaxis is a clinical-stage biotechnology … . For more information please visit: advaxis.com | Facebook | twitter | LinkedIn Forward-Looking … reliance on any forward-looking statements. Advaxis, Inc. Diana Moore, 609-452-9814 Director …
Advaxis Research Accepted for American Association of Immunologists Annual Meeting, Demonstrates Reduction of Tumor Defe
1 May 12:26 GMT

… and adaptive immune responses differentiates Advaxis' Lm-LLO-based immunotherapies from other … small molecule." About Advaxis, Inc. Advaxis is a clinical-stage biotechnology company … . For more information please visit: advaxis.com | Facebook | twitter | LinkedIn Forward-Looking …
Advaxis Research Accepted for American Association of Immunologists Annual Meeting, Demonstrates Reduction of Tumor ...
1 May 12:09 GMT

… and adaptive immune responses differentiates Advaxis' Lm-LLO-based immunotherapies from other … or small molecule.” About Advaxis, Inc. Advaxis is a clinical-stage biotechnology company … . For more information please visit: advaxis.com | Facebook | twitter | LinkedIn Forward-Looking …
Advaxis to Speak at 2012 World Immunotherapy Online Symposium
25 Apr 12:16 GMT

… Target Meeting website. About Advaxis, Inc. Advaxis is a clinical-stage biotechnology company … . For more information please visit: advaxis.com | Facebook | twitter | LinkedIn Forward-Looking … on any forward-looking statements. Contact: Advaxis, Inc. Diana Moore, 609-452-9814 Director …
Advaxis Awarded Best Therapeutic Vaccine
12 Apr 15:15 GMT

… Vaccine Congress website. About Advaxis, Inc. Advaxis is a clinical-stage biotechnology company … the bacteriumto the cancer itself. Advaxis’ lead construct, ADXS-HPV, is being … . For more information please visit: advaxis.com | Facebook | twitter | LinkedIn Forward-Looking …
Advaxis Announces Presentations at World Vaccine Congress 2012
10 Apr 13:18 GMT

… at Advaxis, and Dr. Robert Petit, VP of Clinical Operations at Advaxis … during his presentation. About Advaxis, Inc. Advaxis is a clinical-stage biotechnology company … on any forward-looking statements. SOURCE: Advaxis, Inc. Advaxis, Inc. Diana Moore, 609-452-9814 …
Advaxis Taps Karolinska Researcher to Test Immunotherapies Against Allergies
6 Apr 15:42 GMT

… . van Hage will be using Advaxis immunotherapies to develop allergy treatments … excited about the collaboration with Advaxis and hope to develop an … ,” says Dr. Marianne van Hage. Advaxis has been developing vaccines for … as head and neck cancer. Advaxis adds that over 15 distinct …
Advaxis signs research collaboration with Karolinska Institutet
6 Apr 09:13 GMT

… Writer Published 06 April 2012 Advaxis has signed a research collaboration … to evaluate the potential of Advaxis immunotherapies to treat and prevent … diseases. Karolinska Institutet will use Advaxis immunotherapies to develop allergy treatments … that were developed at Karolinska. Advaxis chairman/CEO Thomas Moore said …
Advaxis Announces Collaboration with the Karolinska Institutet
5 Apr 23:02 GMT

… clinical allergy research. About Advaxis, Inc. Advaxis is a clinical-stage biotechnology company … . For more information please visit: advaxis.com | Facebook | twitter | LinkedIn Forward-Looking … Relations & Business Development dmoore@advaxis.com Printer Friendly Version Email …
Advaxis Announces Abstracts Accepted for Poster Presentation at AACR Annual Meeting 2012
28 Mar 13:16 GMT

… Science and Operations at Advaxis. About Advaxis, Inc. Advaxis is a clinical-stage biotechnology … . For more information please visit: advaxis.com | Facebook | twitter | LinkedIn Forward-Looking … reliance on any forward-looking statements. Advaxis, Inc. Diana Moore, 609-452-9814 Director …
Advaxis Makes Shortlist for Vaccine Industry Excellence Award [Professional Services Close - Up]
25 Mar 11:54 GMT

… [Professional Services Close - Up] Advaxis, Inc., a company developing immunotherapies … over the previous 12 months. Advaxis' ADXS-HPV construct is in … its four Phase 2 trials, Advaxis is sponsoring the CIN 2 … risk management data where appropriate Advaxis: advaxis.com ((Comments on this story …
Advaxis Makes Shortlist for Vaccine Industry Excellence Award [Health & Beauty Close - Up]
22 Mar 11:01 GMT

… & Beauty Close - Up] Advaxis, Inc., a company developing immunotherapies … over the previous 12 months. Advaxis' ADXS-HPV construct is in … its four Phase 2 trials, Advaxis is sponsoring the CIN 2 … risk management data where appropriate Advaxis: advaxis.com ((Comments on this story …
Advaxis Continues Collaboration with Former NCI Vaccines Chief in New Position as Director of the Georgia Health ...
20 Mar 14:26 GMT

Advaxis Inc.Posted on:20 Mar 12 Advaxis, Inc., (OTCBB: ADXS), a … with Advaxis,” Dr. Khleif commented. “My lab has corroborated key Advaxis scientific … Union of Physicians. About Advaxis, Inc. Advaxis is a clinical-stage biotechnology company … . For more information please visit: advaxis.com | Facebook | twitter | LinkedIn Forward-Looking …
Advaxis Named to Shortlist for Vaccine Industry Excellence Award
19 Mar 20:25 GMT

… Vaccine Congress website. About Advaxis, Inc. Advaxis is a clinical-stage biotechnology company … . For more information please visit: advaxis.com | Facebook | twitter | LinkedIn Forward-Looking … on any forward-looking statements. Contact: Advaxis, Inc. Diana Moore, 609-452-9814 Director …
Advaxis to Present at the 6th Annual International BIO-Europe Spring 2012 Conference
16 Mar 14:22 GMT

Advaxis Inc.Posted on:16 Mar 12 Advaxis, Inc., (OTCBB: ADXS), a … caliber partnering opportunities. About Advaxis, Inc. Advaxis is a clinical-stage biotechnology company … . For more information please visit: advaxis.com | Facebook | twitter | LinkedIn Forward-Looking …
Advaxis Low Dose Cohort 1 Meets 50% Efficacy Target In CIN 2/3
27 Feb 14:43 GMT

… .gov, Identifier NCT01116245. About Advaxis, Inc. Advaxis is a clinical-stage biotechnology company … . For more information please visit: advaxis.com | Facebook | twitter | LinkedIn Forward-Looking … on any forward-looking statements. Contact: Advaxis, Inc. Diana Moore Director, Investor …

1 2 3 4 5 6 7 8 9 Next

EIN NEWS REPORT: ADVAXIS			BACK TO TOP

Account Info:

My Account
Subscriber Billing Info
Member Center
- Change your billing and/or user information
- Extend your subscription period
- Re-activate an expired account
- Manage your Email Alerts
- Add additional users to your account
- Manage your additional user account(s)
- Retrieve a lost password
- Get an invoice for your subscription
- Cancel your account by sending us an email through the feedback form

Create an Account:

Help & Information Center:

Submit

About

Navigate:

Tools and Formats:

EIN News Home
About EIN News

Founded in 1995, EIN News is an international leader in real-time news tracking and digital information services. Our systems continuously scan the web, indexing news from thousands of worldwide sources. The data is then filtered and organized into news streams. The process is supervised by a team of professional news editors.

We are news professionals and technologists dedicated to producing the fastest and most comprehensive news streams on the planet. We are committed to providing our members with the highest quality software tools and resources available.

EIN News is a division of Internet Product Development Group Inc.
To reach us send an email or call +1 202 657 5158.
EIN Presswire
EIN Marketplace
EIN Events and Conferences
Newsfeed Maker
Inbox Robot
IPD Group
EIN Twitter
EIN Facebook

+ EIN News Report: Advaxis = Unlimited access to real-time news

Create your EIN News account now.

ALL NEWS PUBLICATIONS

EIN News provides breaking news coverage on the following topics: